Atlas Trials

Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma

Clinical trial NCT02773550 · TERMINATED

Trial details

NCT number
NCT02773550
Sponsor
Basque Health Service
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2014-01-01
Primary completion
2018-07-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.